Knockdown of lncRNA MALAT1 ameliorates acute kidney injury by mediating the miR‐204/APOL1 pathway
Authors:
Open Access
- 9 July 2021
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 35 (8) , e23881
Abstract
Background: Acute kidney injury (AKI) was characterized by loss of renal function, associated with chronic kidney disease, end‐stage renal disease, and length of hospital stay. Long non‐coding RNAs (lncRNAs) participated in AKI development and progression. Here, we aimed to investigate the roles and mechanisms of lncRNA MALAT1 in AKI.Methods: AKI serum samples were obtained from 129 AKI patients. ROC analysis was conducted to confirm the diagnostic value of MALAT1 in differentiating AKI from healthy volunteers. After hypoxic treatment on HK‐2 cells, the expressions of inflammatory cytokines, MALAT1, miR‐204, APOL1, p65, and p‐p65, were measured by RT‐qPCR and Western blot assays. The targeted relationship between miR‐204 and MALAT1 or miR‐204 and APOL1 was determined by luciferase reporter assay and RNA pull‐down analysis. After transfection, CCK‐8, flow cytometry, and TUNEL staining assays were performed to evaluate the effects of MALAT1 and miR‐204 on AKI progression.Results: From the results, lncRNA MALAT1 was strongly elevated in serum samples from AKI patients, with the high sensitivity and specificity concerning differentiating AKI patients from healthy controls. In vitro, we established the AKI cell model after hypoxic treatment. After experiencing hypoxia, we found significantly increased MALAT1, IL‐1β, IL‐6, and TNF‐α expressions along with decreased miR‐204 level. Moreover, the targeted relationship between MALAT1 and miR‐204 was confirmed. Silencing of MALAT1 could reverse hypoxia‐triggered promotion of HK‐2 cell apoptosis. Meanwhile, the increase of IL‐1β, IL‐6, and TNF‐α after hypoxia treatment could be repressed by MALAT1 knockdown as well. After co‐transfection with MALAT1 silencing and miR‐204 inhibition, we found that miR‐204 could counteract the effects of MALAT1 on HK‐2 cell progression and inflammation after under hypoxic conditions. Finally, NF‐κB signaling was inactivated while APOL1 expression was increased in HK‐2 cells after hypoxia treatment, and lncRNA MALAT1 inhibition reactivated NF‐κB signaling while suppressed APOL1 expression by sponging miR‐204.Conclusions: Collectively, these results illustrated that knockdown of lncRNA MALAT1 could ameliorate AKI progression and inflammation by targeting miR‐204 through APOL1/NF‐κB signaling.Keywords
This publication has 66 references indexed in Scilit:
- Diagnosing sepsis – The role of laboratory medicineClinica Chimica Acta, 2016
- miR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expressionOncology Reports, 2016
- AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney diseaseKidney International, 2016
- Circulating MicroRNAs as Biomarkers for SepsisInternational Journal of Molecular Sciences, 2016
- NF-κB transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI)Toxicology Letters, 2016
- The Malat1 long non-coding RNA is upregulated by signalling through the PERK axis of unfolded protein response during flavivirus infectionScientific Reports, 2015
- Systemic Inflammatory Response Syndrome Criteria in Defining Severe SepsisNew England Journal of Medicine, 2015
- Long Noncoding RNAs in Cardiovascular DiseasesCirculation Research, 2015
- Renal Endothelial Injury and Microvascular Dysfunction in Acute Kidney InjurySeminars in Nephrology, 2015
- Splenectomy exacerbates lung injury after ischemic acute kidney injury in miceAmerican Journal of Physiology-Renal Physiology, 2011